These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 9754841)
1. The NMDA antagonist model for schizophrenia: promise and pitfalls. Abi-Saab WM; D'Souza DC; Moghaddam B; Krystal JH Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():104-9. PubMed ID: 9754841 [TBL] [Abstract][Full Text] [Related]
2. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L Encephale; 2001; 27(1):53-9. PubMed ID: 11294039 [TBL] [Abstract][Full Text] [Related]
3. [Receptor antagonist of NMDA and animal models of schizophrenia]. Bian SZ; Zhang J; Liu WL; Sun ZH; Gu ZL; Jiang XG Fa Yi Xue Za Zhi; 2009 Dec; 25(6):443-6. PubMed ID: 20225623 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacological modulation of the effects induced by ketamine at subanesthetic doses]. Mechri A; Micallef J; Blin O; Saoud M; Daléry J; Gaha L Therapie; 2001; 56(5):617-22. PubMed ID: 11806303 [TBL] [Abstract][Full Text] [Related]
5. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002 [TBL] [Abstract][Full Text] [Related]
6. The acute effects of NMDA antagonism: from the rodent to the human brain. Gunduz-Bruce H Brain Res Rev; 2009 May; 60(2):279-86. PubMed ID: 18703087 [TBL] [Abstract][Full Text] [Related]
7. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Bubeníková-Valesová V; Horácek J; Vrajová M; Höschl C Neurosci Biobehav Rev; 2008 Jul; 32(5):1014-23. PubMed ID: 18471877 [TBL] [Abstract][Full Text] [Related]
8. Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? Large CH J Psychopharmacol; 2007 May; 21(3):283-301. PubMed ID: 17591656 [TBL] [Abstract][Full Text] [Related]
9. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Javitt DC Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858 [TBL] [Abstract][Full Text] [Related]
10. Does ketamine mimic aspects of schizophrenic speech? Covington MA; Riedel WJ; Brown C; He C; Morris E; Weinstein S; Semple J; Brown J J Psychopharmacol; 2007 May; 21(3):338-46. PubMed ID: 17591660 [TBL] [Abstract][Full Text] [Related]
11. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Malhotra AK; Pinals DA; Adler CM; Elman I; Clifton A; Pickar D; Breier A Neuropsychopharmacology; 1997 Sep; 17(3):141-50. PubMed ID: 9272481 [TBL] [Abstract][Full Text] [Related]
12. Effects of age and sex on ketamine-induced hyperactivity in rats. Wilson C; Kercher M; Quinn B; Murphy A; Fiegel C; McLaurin A Physiol Behav; 2007 Jun; 91(2-3):202-7. PubMed ID: 17400259 [TBL] [Abstract][Full Text] [Related]
13. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957 [TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process. Ahn KH; Youn T; Cho SS; Ha TH; Ha KS; Kim MS; Kwon JS Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):993-9. PubMed ID: 14499316 [TBL] [Abstract][Full Text] [Related]
15. The vasodilatory effect of ketamine is independent of the N-methyl-D-aspartate receptor: lack of functional N-methyl-D-aspartate receptors in rat mesenteric artery smooth muscle. Noh HJ; Bae YM; Park SH; Kim JG; Kim B; Kim YS; Kim SH; Cho SI; Woo NS Eur J Anaesthesiol; 2009 Aug; 26(8):676-82. PubMed ID: 19352184 [TBL] [Abstract][Full Text] [Related]
16. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo. Shafton AD; Bogeski G; Kitchener PD; Sanger GJ; Furness JB; Shimizu Y Neurogastroenterol Motil; 2007 Jul; 19(7):617-24. PubMed ID: 17539896 [TBL] [Abstract][Full Text] [Related]
18. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia. Wedzony K; Fijal K; Mackowiak M; Chocyk A; Zajaczkowski W Neuroscience; 2008 Jun; 153(4):1370-9. PubMed ID: 18434025 [TBL] [Abstract][Full Text] [Related]
19. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Malhotra AK; Pinals DA; Weingartner H; Sirocco K; Missar CD; Pickar D; Breier A Neuropsychopharmacology; 1996 May; 14(5):301-7. PubMed ID: 8703299 [TBL] [Abstract][Full Text] [Related]
20. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Krystal JH; Perry EB; Gueorguieva R; Belger A; Madonick SH; Abi-Dargham A; Cooper TB; Macdougall L; Abi-Saab W; D'Souza DC Arch Gen Psychiatry; 2005 Sep; 62(9):985-94. PubMed ID: 16143730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]